{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:25:45Z","timestamp":1760955945824,"version":"3.44.0"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"am","delay-in-days":336,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000774","name":"Defense Threat Reduction Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000774","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.jim.2019.03.008","type":"journal-article","created":{"date-parts":[[2019,3,22]],"date-time":"2019-03-22T12:03:41Z","timestamp":1553256221000},"page":"29-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Development and characterization of a Zaire Ebola (ZEBOV) specific IgM ELISA"],"prefix":"10.1016","volume":"468","author":[{"given":"Tanmaya","family":"Atre","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Revell L.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayvon","family":"Modjarrad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason A.","family":"Regules","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elke S.","family":"Bergmann-Leitner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jim.2019.03.008_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2014.09.001","article-title":"Clinical features and pathobiology of Ebolavirus infection","volume":"55","author":"Ansari","year":"2014","journal-title":"J. Autoimmun."},{"year":"2018","series-title":"CM7 Anti-Human IgM","author":"Antibodies","key":"10.1016\/j.jim.2019.03.008_bb0010"},{"key":"10.1016\/j.jim.2019.03.008_bb0015","article-title":"Long-lived antigen-induced IgM plasma cells demonstrate somatic mutations and contribute to long-term protection","volume":"7","author":"Bohannon","year":"2016","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.jim.2019.03.008_bb0020","first-page":"1541","article-title":"Longevity of B-cell and T-cell responses after live attenuated influenza vaccination in children","volume":"211","author":"Bredholt","year":"2014","journal-title":"J. Infect. Dis."},{"issue":"10","key":"10.1016\/j.jim.2019.03.008_bb0025","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/infdis\/jiy080","article-title":"Immunization of malaria-Preexposed volunteers with PfSPZ vaccine elicits long-lived IgM invasion-inhibitory and complement-fixing antibodies","volume":"217","author":"Daubenberger","year":"2018","journal-title":"J. Infect. Dis."},{"year":"2016","series-title":"Ebola Virus Disease-Situation Report","key":"10.1016\/j.jim.2019.03.008_bb0030"},{"key":"10.1016\/j.jim.2019.03.008_bb0035","doi-asserted-by":"crossref","DOI":"10.1038\/srep27944","article-title":"Circulating follicular T helper cells and cytokine profile in humans following vaccination with the rVSV-ZEBOV Ebola vaccine","volume":"6","author":"Farooq","year":"2016","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.jim.2019.03.008_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000225","article-title":"Vesicular stomatitis virus-based ebola vaccine is well-tolerated and protects immunocompromised nonhuman primates","volume":"4","author":"Geisbert","year":"2008","journal-title":"PLoS Pathog."},{"issue":"9996","key":"10.1016\/j.jim.2019.03.008_bb0045","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0140-6736(15)61117-5","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial","volume":"386","author":"Henao-Restrepo","year":"2015","journal-title":"Lancet"},{"issue":"10068","key":"10.1016\/j.jim.2019.03.008_bb0050","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(16)32621-6","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ca Suffit!)","volume":"389","author":"Henao-Restrepo","year":"2017","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.jim.2019.03.008_bb0055","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S1473-3099(17)30313-4","article-title":"Safety and immunogenicity of the rVSVG-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study","volume":"17","author":"Heppner","year":"2017","journal-title":"Lancet Infect. Dis."},{"issue":"7","key":"10.1016\/j.jim.2019.03.008_bb0060","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nm1258","article-title":"Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses","volume":"11","author":"Jones","year":"2005","journal-title":"Nat. Med."},{"issue":"12","key":"10.1016\/j.jim.2019.03.008_bb0065","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1038\/nm.4201","article-title":"Human antibody repertoire after VSV-Ebola vaccination identifies novel targets and virus-neutralizing IgM antibodies","volume":"22","author":"Khurana","year":"2016","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.jim.2019.03.008_bb0070","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1021\/pr800854t","article-title":"Cerebrospinal fluid proteomics reveals potential pathogenic changes in the brains of SIV-infected monkeys","volume":"8","author":"Pendyala","year":"2009","journal-title":"J. Proteome Res."},{"issue":"4","key":"10.1016\/j.jim.2019.03.008_bb0075","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1414216","article-title":"A recombinant vesicular stomatitis virus Ebola vaccine","volume":"376","author":"Regules","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.jim.2019.03.008_bb0080","first-page":"186","article-title":"Update: Ebola virus disease epidemic-West Africa, February 2015","volume":"64","author":"Srivastava","year":"2015","journal-title":"MMWR-Morb. Mort. Wkly Rep."}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175919300420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175919300420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T16:34:00Z","timestamp":1758299640000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022175919300420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":16,"alternative-id":["S0022175919300420"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2019.03.008","relation":{},"ISSN":["0022-1759"],"issn-type":[{"type":"print","value":"0022-1759"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and characterization of a Zaire Ebola (ZEBOV) specific IgM ELISA","name":"articletitle","label":"Article Title"},{"value":"Journal of Immunological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jim.2019.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}